Home/ Stocks/ FRNM

Freenome, Inc. Common stock

FRNM XNAS

$10.18 -0.17 (-1.62%) ▼ 15-min delayed

Open

$10.61

High

$10.61

Low

$9.71

Volume

2.46M

Market Cap

$1.09B

About Freenome, Inc. Common stock

Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.

Sector: SERVICES-MEDICAL LABORATORIES Website →

Related Market News

No specific coverage for FRNM yet. Check out our latest market news or earnings calendar.

Get FRNM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Freenome, Inc. Common stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.